灵活的基架化学信息学方法用于多药物设计
Zhangcheng Chen1, Jing Yu1, Huan Wang2
1Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Cell
|March 29, 2024
概括
设计用于中枢神经系统 (CNS) 疾病的多种药物具有挑战性. 一种新的基于基架的灵活化学信息学方法 (FSCA) 通过利用特定的结合姿势实现了合理的药物设计.
科学领域:
- 医学化学
- 神经科学
- 计算化学
背景情况:
- 中枢神经系统 (CNS) 复杂疾病的治疗需要具有多药性和多功能性的药物.
- 设计多目标药物仍然是药物化学的一个重大挑战.
研究的目的:
- 提出一种基于灵活支架的新型化学信息学方法 (FSCA),用于合理设计多种药物.
- 使用针对5-HT2A和5-HT1A受体的新型化合物证明FSCA的应用.
主要方法:
- FSCA涉及将灵活的支架安装在不同的受体上,使用不同的结合姿势.
- 对氨基受体结构的分析确定了关键动机:"激素过器"和"形状塑造器".
- 化合物IHCH-7179是使用FSCA设计的,在5-HT2A和5-HT1A受体上采用不同的结合姿势.
主要成果:
- IHCH-7179是5-HT2A受体的对抗剂,也是5-HT1A受体的激动剂.
- 在小鼠模型中,IHCH-7179在缓解认知缺陷和精神症状方面表现出有效性.
- 已识别的基因预测了对氨基受体的联体结合姿态和活性.
结论:
- FSCA提供了一个合理的策略来设计多种药物.
- 已识别的基因对于预测氨基受体的配体行为至关重要.
- 可以将FSCA扩展到设计用于其他受体标的多药联体.
相关概念视频
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Model Approaches for Pharmacokinetic Data: Compartment Models
93
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
93
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
123
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
123
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254


